Cargando…
Specific and Sensitive Detection of Neuroblastoma mRNA Markers by Multiplex RT-qPCR
SIMPLE SUMMARY: Sensitive detection of minimal residual disease by RT-qPCR in patients with neuroblastoma is shown to be predictive of outcome, but has not yet been introduced into clinical practice. A panel of multiple mRNA markers increases the sensitivity of minimal residual disease detection, si...
Autores principales: | van Zogchel, Lieke M. J., Zappeij-Kannegieter, Lily, Javadi, Ahmad, Lugtigheid, Marjolein, Gelineau, Nina U., Lak, Nathalie S. M., Zwijnenburg, Danny A., Koster, Jan, Stutterheim, Janine, van der Schoot, C. Ellen, Tytgat, Godelieve A. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796198/ https://www.ncbi.nlm.nih.gov/pubmed/33466359 http://dx.doi.org/10.3390/cancers13010150 |
Ejemplares similares
-
Cell-Free RNA from Plasma in Patients with Neuroblastoma: Exploring the Technical and Clinical Potential
por: Lak, Nathalie S. M., et al.
Publicado: (2023) -
Hypermethylated RASSF1A as Circulating Tumor DNA Marker for Disease Monitoring in Neuroblastoma
por: van Zogchel, Lieke M. J., et al.
Publicado: (2020) -
Improving Risk Stratification for Pediatric Patients with Rhabdomyosarcoma by Molecular Detection of Disseminated Disease
por: Lak, Nathalie S.M., et al.
Publicado: (2021) -
Mesenchymal Neuroblastoma Cells Are Undetected by Current mRNA Marker Panels: The Development of a Specific Neuroblastoma Mesenchymal Minimal Residual Disease Panel
por: van Wezel, Esther M., et al.
Publicado: (2019) -
Cell-Free DNA as a Diagnostic and Prognostic Biomarker in Pediatric Rhabdomyosarcoma
por: Lak, Nathalie S.M., et al.
Publicado: (2023)